<SEC-DOCUMENT>0000950170-25-109932.txt : 20250819
<SEC-HEADER>0000950170-25-109932.hdr.sgml : 20250819
<ACCEPTANCE-DATETIME>20250819070027
ACCESSION NUMBER:		0000950170-25-109932
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20250819
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250819
DATE AS OF CHANGE:		20250819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aldeyra Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001341235
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36332
		FILM NUMBER:		251229624

	BUSINESS ADDRESS:	
		STREET 1:		131 HARTWELL AVENUE
		STREET 2:		SUITE 320
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
		BUSINESS PHONE:		781-761-4904

	MAIL ADDRESS:	
		STREET 1:		131 HARTWELL AVENUE
		STREET 2:		SUITE 320
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aldexa Therapeutics, Inc.
		DATE OF NAME CHANGE:	20130102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Neuron Systems Inc
		DATE OF NAME CHANGE:	20051012
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aldx-20250819.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-08-18T19:40:25.0081+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:aldx="http://www.aldeyra.com/20250819" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_7b26f16c-c78a-49bf-ad16-71b6da387efe" name="dei:EntityCentralIndexKey" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360">0001341235</ix:nonNumeric><ix:nonNumeric id="F_b96d9d44-debf-4e74-82f4-f82da2e3e21d" name="dei:AmendmentFlag" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" format="ixt:fixed-false">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="aldx-20250819.xsd"/></ix:references><ix:resources><xbrli:context id="C_f19ad44d-647b-481c-bf31-53994eb97360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001341235</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-19</xbrli:startDate><xbrli:endDate>2025-08-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.25pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:16pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1a90d194-0a26-4320-943e-0f99a2f2c2bc" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.25pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the Securities Exchange Act of 1934</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aeb6ef36-d8bb-4b5b-b397-260df7c50884" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">August 19, 2025</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.25pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:16pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9c5163ab-b8f6-474e-ad03-c3c08ed8e85d" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ALDEYRA THERAPEUTICS, INC.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as specified in its charter)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.25pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:45%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:22.12%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:30.88%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ea73ae7c-3933-46d3-a339-6125883d51ea" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_603139cf-c295-4d97-a4a6-4bda021ff651" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-36332</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_cb31cb55-a644-4cc2-8f88-72af22260501" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">20-1968197</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">of incorporation)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">File No.)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8ce705e4-eeb1-4e15-80a8-03eb4576f835" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">131 Hartwell Avenue</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_160770b5-7163-4be2-afa4-0345501088fd" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Suite 320</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2ea42e45-a36e-4f56-bdff-72662ab5cab8" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lexington</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dc8b6cec-b74f-4f25-881d-1466fa06eea6" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MA</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_313525a3-2483-429a-ba9b-5d9c40011a87" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">02421</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Address of principal executive offices and zip code)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_277af634-def2-4e54-a593-557be14536af" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">781</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b28fdbd4-790c-4e00-a9d4-650d54b1aaa1" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">761-4904</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not Applicable</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.25pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:2.36%;box-sizing:content-box;"/>
     <td style="width:97.64%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_e7ddc68b-21ce-4980-9e7e-7beac90ae78e" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:2.34%;box-sizing:content-box;"/>
     <td style="width:97.66%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_ffb9ba79-ff91-4239-a346-ee6dc113e9d5" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:1.9%;box-sizing:content-box;"/>
     <td style="width:98.1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_9fadafb4-5607-44d2-a902-7107f3e3cf46" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:1.9%;box-sizing:content-box;"/>
     <td style="width:98.1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_9e2acebd-29a6-408d-aa6f-011e8dc384d9" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:49.74%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.34%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:36.92%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Symbol(s)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6587283a-70bb-4364-9933-887578a759bb" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock, $0.001 par value per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_fcdb31dd-8fe1-4074-b323-edbea9e00de7" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ALDX</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">The </span><span><ix:nonNumeric id="F_5b6bb2b8-d26b-4825-a4a4-8989f3e57a9f" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Nasdaq</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;Stock Market LLC</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_75872da6-bd71-41d5-a669-ce729640d387" contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:41.68%;box-sizing:content-box;"/>
     <td style="width:58.32%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Item 8.01.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other Events.</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 19, 2025, Aldeyra Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release (the &#8220;Press Release&#8221;) to announce that the U.S. Food and Drug Administration has granted Fast Track Designation for ADX-2191 for the treatment of retinitis pigmentosa. The Press Release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:22.2%;box-sizing:content-box;"/>
     <td style="width:77.8%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Item 9.01.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Financial Statements and Exhibits.</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d) Exhibits</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:8.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:90.38%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;text-indent:8pt;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;"><p style="text-indent:-1.502%;padding-left:1.48%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit<br/>No.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;"><p style="text-indent:17.773%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="aldx-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid #0000ee;font-kerning:none;min-width:fit-content;">Aldeyra Therapeutics, Inc. Press Release dated August 19, 2025</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURE</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:51.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:9.32%;box-sizing:content-box;"/>
     <td style="width:90.68%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ALDEYRA THERAPEUTICS, INC.</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0.021in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Todd C. Brady</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name: Todd C. Brady M.D., Ph.D.</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title: Chief Executive Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dated August 19, 2025</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>aldx-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2025-08-18T19:40:25.5283+00:00 --><!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.75in;z-index:2;min-height:1.38in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;margin-left:0;margin-right:0;"><img src="img112526854_0.jpg" alt="img112526854_0.jpg" style="width:151px;height:76px;"><font style="color:#595959;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:'Open Sans',sans-serif;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:14pt;font-family:'Open Sans',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;"><br>Aldeyra Therapeutics Receives Fast Track Designation for ADX&#x2011;2191 for the Treatment of Retinitis Pigmentosa</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"><br> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">LEXINGTON, Mass., August 19, 2025</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> &#x2013; </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aldeyra Therapeutics, Inc.</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA)</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">has granted fast track designation for ADX-2191 (methotrexate intravitreal injection, USP) for the treatment of retinitis pigmentosa. There is currently no approved treatment for patients with most forms of retinitis pigmentosa, a clinical group of rare genetic eye diseases characterized by retinal cell death and loss of vision. Retinitis pigmentosa affects more than one million people worldwide.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x201c;Although retinitis pigmentosa is a relentlessly progressive condition that has been recognized for decades as a significant cause of blindness, there are no approved therapies for most forms of the disease,&#x201d; stated Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra. &#x201c;Fast Track Designation in conjunction with the previously announced Orphan Drug Designation underscores the potential for ADX-2191 to address an unmet need in the field of ophthalmology and creates the framework for ADX-2191, if approved, to reach patients promptly.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The potential activity of ADX-2191 in retinitis pigmentosa is supported by results from a Phase 2 clinical trial, announced in 2023, which demonstrated improvements from baseline in retinal sensitivity following treatment. A planned Phase 2/3 clinical trial of ADX-2191 in retinitis pigmentosa is expected to initiate in 2025.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Fast Track Designation is designed to facilitate the development and expedite the review of drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address an unmet medical need. Fast Track Designation enables frequent FDA interactions and may allow for rolling review, priority review, or accelerated approval if relevant criteria are met.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">   </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1.56in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.75in;z-index:2;min-height:1.38in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About ADX-2191</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">ADX-2191 (methotrexate injection, USP) is a sterile, non-compounded intravitreal formulation of methotrexate for the potential treatment of specific rare retinal diseases, including primary vitreoretinal lymphoma and retinitis pigmentosa. The ADX-2191 intravitreal formulation is preservative-free, is designed to be vitreous-compatible, and is optimized for excipient composition, viscosity, density, tonicity, pH, concentration, and volume of administration. ADX-2191 has received FDA Orphan Drug Designation for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa, Fast Track Designation for the treatment of retinitis pigmentosa, and EMA Orphan Designation for the treatment of inherited retinal dystrophies of the rod-dominant phenotype, including retinitis pigmentosa, and the treatment of primary large B-Cell lymphomas of immune privileged sites, including primary vitreoretinal lymphoma.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About Retinitis Pigmentosa</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Retinitis pigmentosa is a group of rare genetic eye diseases characterized by retinal cell death and loss of vision. There are currently no approved treatments for most forms of retinitis pigmentosa. In vivo preclinical research has identified the activity of methotrexate in inducing misfolded rhodopsin (a visual cycle protein) clearance, suggesting the potential of ADX&#x2011;2191 to treat genetic forms of retinitis pigmentosa that are characterized by misfolded rhodopsin.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About Aldeyra</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Aldeyra Therapeutics is a biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated and metabolic diseases. Our approach is to develop pharmaceuticals that modulate protein systems, instead of directly inhibiting or activating single protein targets, with the goal of optimizing multiple pathways at once while minimizing toxicity. Our product candidates include RASP (reactive aldehyde species) modulators ADX-629, ADX&#x2011;248, ADX-743, ADX-631, ADX-246, and chemically related molecules for the potential treatment of systemic and retinal immune-mediated and metabolic diseases. Our late-stage product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the potential treatment of primary vitreoretinal lymphoma and retinitis pigmentosa.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1.56in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="border-top:0.5pt solid #3c0d7b;padding-top:8pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Open Sans',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.75in;z-index:2;min-height:1.38in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Safe Harbor Statement</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Aldeyra&#x2019;s future expectations, plans, and prospects, including without limitation statements regarding: the goals, opportunity, and potential for ADX-2191; and the outcome and timing of any clinical trials of ADX-2191. Aldeyra intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as, but not limited to, &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;will,&#x201d; &#x201c;objective,&#x201d; &#x201c;intend,&#x201d; &#x201c;should,&#x201d; &#34;could,&#34; &#x201c;can,&#x201d; &#x201c;would,&#x201d; &#x201c;expect,&#x201d; &#x201c;believe,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;project,&#x201d; &#x201c;on track,&#x201d; &#x201c;scheduled,&#x201d; &#x201c;target,&#x201d; &#x201c;design,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;contemplates,&#x201d; &#x201c;likely,&#x201d; &#x201c;potential,&#x201d; &#x201c;continue,&#x201d; &#x201c;ongoing,&#x201d; &#x201c;aim,&#x201d; &#x201c;plan,&#x201d; or the negative of these terms, and similar expressions intended to identify forward-looking statements. Such forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions, and uncertainties. Aldeyra is at an early stage of development and may not ever have any products that generate significant revenue. All of Aldeyra's development timelines may be subject to adjustment depending on recruitment rate, regulatory review, preclinical and clinical results, funding, and other factors that could delay the initiation, enrollment, or completion of clinical trials. Important factors that could cause actual results to differ materially from those reflected in Aldeyra's forward-looking statements include, among others, the timing of enrollment, commencement and completion of Aldeyra's clinical trials, the timing and success of preclinical studies and clinical trials conducted by Aldeyra and its development partners; delay in or failure to obtain regulatory approval of Aldeyra's product candidates, including as a result of the FDA not accepting Aldeyra&#x2019;s regulatory filings, issuing a complete response letter, or requiring additional clinical trials or data prior to review or approval of such filings or in connection with resubmissions of such filings; the ability to maintain regulatory approval of Aldeyra's product candidates, and the labeling for any approved products; the risk that prior results, such as signals of safety, activity, or durability of effect, observed from preclinical or clinical trials, will not be replicated or will not continue in ongoing or future studies or clinical trials involving Aldeyra's product candidates in clinical trials focused on the same or different indications; the scope, progress, expansion, and costs of developing and commercializing Aldeyra's product candidates; uncertainty as to Aldeyra&#x2019;s ability to commercialize (alone or with others) and obtain reimbursement for Aldeyra's product candidates following regulatory approval, if any; the size and growth of the potential markets and pricing for Aldeyra's product candidates and the ability to serve</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1.56in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="border-top:0.5pt solid #3c0d7b;padding-top:8pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Open Sans',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.75in;z-index:2;min-height:1.38in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">those markets; Aldeyra's expectations regarding Aldeyra's expenses and future revenue, the timing of future revenue, the sufficiency or use of Aldeyra's cash resources and needs for additional financing; the rate and degree of market acceptance of any of Aldeyra's product candidates; Aldeyra's expectations regarding competition; Aldeyra's anticipated growth strategies; Aldeyra's ability to attract or retain key personnel; Aldeyra&#x2019;s commercialization, marketing and manufacturing capabilities and strategy; Aldeyra's ability to establish and maintain development partnerships; Aldeyra&#x2019;s ability to successfully integrate acquisitions into its business; Aldeyra's expectations regarding federal, state, and foreign regulatory requirements; political, economic, legal, social, and health risks, public health measures, and war or other military actions, that may affect Aldeyra&#x2019;s business or the global economy; regulatory developments in the United States and foreign countries; Aldeyra's ability to obtain and maintain intellectual property protection for its product candidates; the anticipated trends and challenges in Aldeyra's business and the market in which it operates; and other factors that are described in the &#x201c;Risk Factors&#x201d; and &#x201c;Management's Discussion and Analysis of Financial Condition and Results of Operations&#x201d; sections of Aldeyra's Annual Report on Form 10-K for the year ended December 31, 2024, and Aldeyra&#x2019;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, which are on file with the Securities and Exchange Commission (SEC) and available on the SEC website at https://www.sec.gov/. Additional factors may be described in those sections of Aldeyra&#x2019;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, expected to be filed with the SEC in the fourth quarter of 2025, and Aldeyra&#x2019;s other filings with the SEC.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In addition to the risks described above and in Aldeyra's other filings with the SEC, other unknown or unpredictable factors also could affect Aldeyra's results. No forward-looking statements can be guaranteed and actual results may differ materially from such statements. The information in this release is provided only as of the date of this release, and Aldeyra undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Investor &amp; Media Contact:</font></p>
   <table style="border-spacing:0;table-layout:auto;width:54.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12.95pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Laura Nichols</font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1.56in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="border-top:0.5pt solid #3c0d7b;padding-top:8pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Open Sans',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.75in;z-index:2;min-height:1.38in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:54.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:7.2pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">Tel: (781) 257-3060</font></p></td>
    </tr>
    <tr style="height:12.95pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:top;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">investorrelations@aldeyra.com</font><font style="color:#0563c1;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:14.4pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1.56in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="border-top:0.5pt solid #3c0d7b;padding-top:8pt;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Open Sans',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img112526854_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img112526854_0.jpg
M_]C_X  02D9)1@ ! @$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $( @P# 2(  A$! Q$!_\0
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MJ^:I)R[+HO1;+Y+7J(RJZLCJKHRE65@&5E88964Y!4@D$$$$'!XK\I?VSO\
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MX^'WA3P?#%&(C/HVCVD&IW*@,-^H:R\<FKZG,5=D-QJ-]=3LAV-(4  ])(#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW7PR^Y6;Z6CU9^./[7GP#N_V=/CAXH\"I'.WA>\D'B3P)?3*^+SPEJ\LTEC
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:&TUFQTW4X1#J>FWMHRW=E;N7MV=%:)D=O3*_*+_ ((=?\HJOV/O^Q.\:?\
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M5?L??]B=XT_]6QX_K]7:_*+_ ((=?\HJOV/O^Q.\:?\ JV/']?J[7\?<5_\
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M>@X4H.K4A2IJ4KZ.=2I"$>\I)#E0K0BY2IRC%6NVM%=V7XM(_0*BO@/XR_\
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MT/4X9)++7?"^O6\,DJ6>O^&=9MKW1=8MEDDC2]LY)+:6XM)+>XE_E/Q#\/\
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M-%$CV/Q OK>XW-#XQU=Y/ RO:JVEZ1XXTS4(]0M/G3_@X(_X*^:[KOB;Q?\
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M.>)JTIIV<*T,+"LZ4U]J%11E'=I(QGB*$':56*?57NUZVO;Y^NQ_+'7Z>_\
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ME.S>7YGC5?B'=[H]D4GVGB,3)/++_0;\7OA?X5^-OPJ^)'P>\<6GVWP?\4?
M_BCP#XEMU"&5M&\6:+>:)?R6S.K"&]M[>]>XL;E0)+6\B@N(F66)&'\?2E4\
M/_$";I.;I9)G#25W[2ME=9ZTW=_'7RVORMMM*<^;5+7Q-<-B=+VIU/FX/=>K
M@_OU/\@ROZ?/^#8/]J__ (5M^U#\1?V5?$.HM'X;_:+\*GQ%X,MYY96B@^*/
MPML=3UA[:SB+BVM#XC^'\_BF;4[C:);VX\(^'+/+E(5'\[7QV^#_ (J_9]^-
M'Q4^!WC>+R_%?PF\?>*O &MNL3PP7EYX8UB[TK^U+%79R^F:O%;1:II=PKR1
M76G7EK<PRRPRI(S/@;\7_%O[/_QD^%WQO\"7/V;Q?\*/'?ACQ[H#,[)!<7_A
MG5[75%T^^"AA-IFJ1V\FFZI:R))#>:==W5K/%+#-)&W]<\293A^*N&<PRV$Z
M=2&98'GP5:]Z:KJ,<3@,0GOR*O"C4;5G*G=72;/:JP5:E*&C4X^Z^E]XOTO9
M^A_KR45YS\'_ (I>$_C?\*?AQ\8_ MZ-0\'?%#P1X9\>>&KG=&TC:1XIT>TU
MBSANEC9UAOK6*[%KJ%JQ$MI?0W%K,J30R(OHU?P;4IU*-2I2JPE3JTIRIU(2
M34H5(2<9PDGJI1DFFGJFFCYUIIM/1IV:[-!7X+_\'#G[9'_#,W["^L?"_P ,
MZP^G_$[]JB]O?A5HBVDWEW]G\.H+>WO/BYK2XDC;[%<>'[NQ\"7)3?*LGCV"
M:),022P_O17^:_\ \%VOVQC^UQ^WU\0;7P[K#:E\*_@ LGP1^'8M[A9=,O+G
MPS>W#?$'Q/:""::RN&\0>.Y-8M[/6+9F.K>%=%\*M(^RVABB_1_"KAS_ %@X
MLPDZU/GP.3I9IB[J\)SHSBL'0=TXMU<4Z<Y4Y:5*%&NNC.K!TO:UHM_#3]]^
M;3]U?-Z^:3/QGK]U_P#@WN_8['[3W[>?ASX@^(]+:]^&G[+5I9?&/Q"\T+/8
MWGCR&\>U^$6A23*ZB&[_ .$KMYO&\"2I+!>V7@#5+&9-EQN'X45_I'?\$%/V
M.O\ AD_]@7P)K7B'37LOB=^T<]M\<?&XNH/*OM.T?Q%IMM'\-O#4H8B>)-+\
M#IINLW5A=10W6F>(_$WB.SGB5XR*_H;Q4XC_ -7^$\7&C4Y,=F]\KPG*[3A&
MO"7UNNK>]'V6%52,9IIPKU:#33:/3QE7V5&5G:4_<CWU^)^5HWUZ-H_:JOY>
M/^#JC_DSS]G?_LY6'_U5WC^OZAZ_EX_X.J/^3//V=_\ LY6'_P!5=X_K^:/#
M3_DNN'/^PV?_ *BX@\G"?[Q2_P 7Z,_A.K]E/^"''[!WAW]NC]L_3M-^)>E?
MVO\ !+X)Z WQ5^)FDS*?L'BV:TU.RTSP9\/[YPKYL_$VOW0U#6K5T5-2\)>'
M/$VFI<VEU=VTZ?C77]GW_!ISI=@GA/\ ;>UI;9!JESXB^ FES7A+M(;"RTWX
ML7=M;(K,8XD6XU"ZED,2(\[/&+AI5MK80_U3XC9KBLEX,SS'X*<J6*5"AAJ-
M6#Y9TGC<70P<ZL)+6-2G3KSG3E'6-11:LU=>QBIRAAZDHNS223[<TE%M>:3T
M\S^N^PL+'2K&RTO2[*TTW3--M+:PT[3K"VAL[&PL;.%+>TLK*TMTCM[6TM;>
M.."VMH(XX8(8TBB1455%NBBOX>;;;;;;;NV]6V]VWU;/GPHHKY__ &KOC$/V
M>_V8_P!H+XY*\*W7PF^#?Q&\>Z7'<(DL5WKGAKPIJFIZ!IQBD98I7U/6[>PT
MZ**5TBEENDCDDC1F==</0J8JO0PU&/-6Q%:G0I1VYJE6<:<(W\Y22&DVTENV
MDO5Z'\#'_!?[]M[4/VK?VWO$_P -?#VLRW/P=_9<N]8^%'A"Q@G9M-U+QW9W
M<</Q8\8>4"T4EW>>)[!?"5I=PR2VMUX?\&Z-?6IC-_=&7\+JMW]_>ZI?7NIZ
ME=W%_J.HW=S?W]]=RO/=7E[>3/<75W<SR%I)KBXGDDFFED9GDD=G8EF)K]%O
M^"2_[)>G?MH?MY?!#X.^)K'^T/AW9:M>?$;XI6SC-O>> ?A];'Q!J6B7N%9Q
M9^+]3@T?P3</%LFB3Q)YT<L+1B:/^\,+0R[@[AF%)?N\OR'+)U*THQ2G56&H
MRK8FMRW2E7Q555*K5USUJK2M=(^BBHT*25_=IPU=M^57;MW;N[+JS^A7_@A;
M_P $2?"<WA'P?^VM^V)X-M/$NH^*+2Q\3? 7X+>*-/CNM!TG0+CR;[0_BGX[
MTFZ#V^MZIKUOY.H>"?#.HP2Z1I>B3V_B/5;;4=8U/2H/#']@*JJ*J(JHBJ%5
M5 5551A551@!0      ,#BHK:VM[.W@M+2"&UM+6&*VM;6VB2"WMK>!%BA@@
MAB58X888U6.**-52-%5$4* !-7\5\3\39GQ7FE;,\QJR:E*4<)A5)O#X'#7]
MS#T(/1)14?:5+*=>HG5J-R>G@UJTZTW.;_PQZ179?J]V]6%%%%?.F1X!^TM^
MR[\#?VO/A9K7P<^/_@+2?'?@O6$>2!+Q/(UGPYJPADAM/$GA+78-NI>&_$6G
MB5S::IIL\,C1M+9W:W6G75W9W'^;)_P4\_X)U^/_ /@G%^T/>?#'7+J]\4?#
M'Q=#>^)?@K\29[1+=?&'A&*XBBNM/U18%6SM_&7A&>ZM=*\66-N(XS)/INN6
MMM;:5K^EQU_J-5^0'_!<7]D/2_VLO^"?OQ;-MIR7'Q&^ VDZE\>/AM?1Q%[Y
M;OP'I5[?^,?#\ ABDNKM/%?@1?$&F6VE1,L5YXC3PW=RK))IMN%_4/##C7%\
M-YWA<OQ%><\CS3$4\-B</4DW2PM>O*-.ECZ*;M2E"HX+$\JM5P_-SQE4IT90
M[,)B)4JD8-_NYNS3V3=DI+LUI?HU>^J37^:-7^C;_P $ OVW;_\ :[_8CTSP
M?XVU675/BY^S+?:=\)_%][=SB?4->\'FPDNOA9XLNR6>9I;SP[9W?A.\NKN2
M2[U36?!&L:O.Q:_ '^<E7]"O_!M3^T$/A/\ \%!C\*M2OF@T#]I#X9^*? \=
MO([)9GQIX/A_X6+X6O9VWK&+@:7X>\6Z#8>8&\VZ\2+;1#SKB,']_P#%;(:>
M=\'X^JJ:EC,GB\UPLTKSC##J^-A?XN2I@_;2E!.SJ4Z,VFZ<3TL93]I0D[7E
M#WX]]/B^^-].Z75(_P!".BBBOXP/!/\ )D_;:N[F_P#VS?VN;Z]GENKR\_:=
M^/=W=W,SF2:XN;CXJ^*YIYYI&)9Y997>21V)+.Q8G)J_^PAH&G>+/VX?V-/"
MVL1M+I/B7]JW]G?0-4B41%I=.UGXN^#].OHU$\4\)9[:YE4":&:(DXDBD3*'
MT+_@I_\ #BZ^%'_!0_\ ;-\&75NUJD?[0_Q,\3Z7;MYF8?#WQ \17?Q \,1[
MYI[F:95\.>)]+"W$TSRW*XN)0CR-&OR;\*_'VI?"KXG_  X^*&C(LNK_  W\
M>^#_ !]I4;%0LFI>#_$.G>(;%&+I(@5[K3HE)>.10#\R.,J?[]PJ^N\-X982
M2OB\DHK#3345^_P$?8RNM$O?B[IV1])'WJ4;=::M\XZ'^OY17*^!?&OAOXD^
M"/!WQ%\':C%K'A#Q]X5\/>-?"NKP?ZG5/#?BG2+/7-#U&'!(\J^TR_M;F/!/
MR2CD]:ZJOX$G&4)2A.,H3A)QG"2<91E%M2C*+LU*+3335TU9GS>VX4445(!1
M110!_G1?\''>B:;I7_!4;XD7]C;)!=>)OAE\'=;UF5516O-2M_!EIX<BN9"J
MJ7==(\/Z5:!I"[B.UC0,$5$3\)*_4[_@M1\=M-_:#_X*6_M.^+M OAJ'ACPM
MXJTSX3^'9HKAKJU:W^%'A[2_ VM3V$Q C>QU+Q=HWB/6+5[=?L\D>HB6)YU?
M[3-^6-?WIP=0K87A3AO#XA2C7I9)ED*D)7YJ<EA*3]E*^SI)JFULG&RT1]'0
M35&DGNJ<+KM[JT^6Q_I0_P#! [X_I\>O^"9OP1@N[_[=XD^",^O_  $\2!IC
M*]H/ 5S#<^"[,A_GB2W^&.N^!HXXR610I6(B-5C3]EZ_BC_X-5/V@AI/Q,_:
M7_9?U2^80>,_"7A[XT^#[25V6"+5?!.I)X0\:1VH+B-[[5]+\6^$KF2)4,TE
MEX6EF4^5:R[?[7*_D/Q'RC^QN,\\PT8\M'$8IYCA]+1=+,(K%-07\E*M4JT$
MNCI-+17/$Q4/9UZBZ-\R])>]IZ-M?(_A-_X.J/\ D\3]GC_LVF#_ -6C\0:_
MEYK^H;_@ZH_Y/$_9X_[-I@_]6C\0:_EYK^J/#;_DAN'/^P&7_J37/8PG^[TO
M\/ZL_P!-O_@AU_RBJ_8^_P"Q.\:?^K8\?U_(]_P<IWEU=?\ !3778+B=Y8M.
M^"?PEL[&-R-MM:O::UJ#P1X PC7M_>7)!R?,N)#G! ']</\ P0Z_Y15?L??]
MB=XT_P#5L>/Z_EQ_X.A?AI=^%_V\OAW\1$@8:/\ %+]GOPLZW96<+)XB\%>*
M_&&@:Q9AI)987:UT27PE<,;86R :@JR6HE#7=Y^->']2G#Q=XCC-I2K8GB>G
M23ZU%F;K-+S]E2J/3HGTN<&%:6-JWZNJEZ\]_P DS^;*O]5K_@F?H>G>'O\
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MHK^B/_B&,_X*/_\ 0<_9J_\ #G^*O_G:T?\ $,9_P4?_ .@Y^S5_X<_Q5_\
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MLZ,IM.O!/V,#652DJ;?OTU:W>'V7\OA?HNY_9#_P;A?\%-="\:_#O3_^"?\
M\8O$$5C\1/A_%J=Y^SUJVJW6T>-_A^SW6LZK\.XYYU^?Q)X!G>_U#0;5[J27
M4O!%R--TVRMK;P-,]Y_6!7^.[H.O:YX6UO2/$WAC6M6\.>)/#VIV.M:!X@T'
M4;S1];T/6=,N8[W3=6TC5=/FM[_3=3T^\AAN[&_LKB"ZM+F*.>WECEC5Q_7?
M_P $]_\ @YH;0=$T7X7_ +?_ (:UK7GTZWMM-TS]H;X=Z5;7NKW<$$<4,<OQ
M/\!Q2V1O;M4266\\5^"6DN[UC;Q2^!YKHWFL3?&^)7A7CJ^/Q/$'#.'^M0Q<
MY5\PRJE98BGB9OFK8G!P=E7IUY-U:N'B_;0K2E*C&I3GR4>?%X.3DZM)<REK
M*"W3ZN*ZI[M;IWM=.R_LSHKXK^$W_!1S]@WXX6%I?_#3]KCX"ZV]ZBR0Z+J7
MQ$T#PCXM5&C\T-<^"O&5WX?\7V6$#%A>Z';E&21& >*15['Q]^W!^QK\+=,D
MU;XA?M5?L]>$[-(O-1=5^+_@.._O 1*5CTS28]=EU75KAQ;W!CM=,LKNYE$$
MYCB80R;?P>>49K3K_5IY9F$,3?E^KSP6)C7YKVY?9.DJE[Z6Y;W/.Y)IV<)7
M[<KO]UCZCK\<O^"S7_!2SPY^P%^S=K6D^$_$%BW[3?Q?T34_#GP<\/6]Q!-J
MWAB&_BGT[5/BYJ=CYADM-(\(*T\GAZ:[@DM=;\91:=IBVU[86NOM8? O[<'_
M  <S?L\_#32-:\'_ +%GA^\^/?Q&DAN;.S^)'BK2=:\)_!SPW><Q"_BT[4X]
M(\<>/I[29)%_LZVL/"6A7:-!?67BZ_MPUM-_%;\=_CU\6_VF/BEXH^,WQP\;
M:OX_^(OB^[%SJ^O:O*GR0Q+Y5CI.E6-ND-AHN@Z3;!+/1]#TJVM-,TRSCCM[
M.VBC7!_8/#_PGS/'XW#9KQ+A*F RO#SA7A@,5'DQF83@U*%*MAY>_AL(VOW_
M +=0K58KV5.FHU'6I]V&P4Y24ZJ<8*S47\4GNDUTCWO9O9+6Z\CDDDFDDEED
M>665VDEED9GDDD=BSR2.Q+.[L2S,Q+,Q))))-,HHK^J#V#]&_P#@DE^T G[-
M/_!13]EGXDWUY]B\.WGQ(LOASXOFD8BSA\*_%BUNOAQJVHZ@JLK267A]?$T7
MB9PHDD27189H8+B:*."3_4=K_'*CDDADCEBD>*6)UDBEC9DDCD1@R21NI#(Z
M, RLI#*P!!! -?ZQ'[#'Q\3]J']C[]G'X]M.MQJ?Q(^$WA/5_%#(8V2+QQ9:
M>FB>/K.-H@J/%8>-=+U^RBD\N%I([=7>WMG9H(_YN\><IY:V19[".E2G7RK$
MRMLZ4GB\&O-R53&WOJE36ZV\K,8:TZBZIP;]-8_G+[C^/K_@ZH_Y/$_9X_[-
MI@_]6C\0:_EYK^H;_@ZH_P"3Q/V>/^S:8/\ U:/Q!K^7FOUGPV_Y(;AS_L!E
M_P"I-<[<)_N]+_#^K/\ 3;_X(=?\HJOV/O\ L3O&G_JV/']?"W_!S)^RE??&
M;]C;PE^T)X:L'OO$W[+/B^YU/7(X$,EP_P +/B6^C>'/%UQ%#$K37#Z-XFTS
MP%K$[8:'3M!M?$>HS&*"">4?=/\ P0Z_Y15?L??]B=XT_P#5L>/Z_3GQCX0\
M,_$'PCXH\!^-=%L?$G@[QKX>UGPIXJ\/:G$9M.USPYXATZXTG6M(OH@RM)::
MCIUW<VEPJNC&*5MKJV&'\LU\ZJ\.^(N8YU13E+ <4YM5J4XM)U<//,,52Q5%
M-Z)UL-4JTE)Z1<[ZV/']HZ6*E47V:TVTNJYFI+YIM?,_QZZ_?#_@@G_P4NT;
M]A[]H#6/A5\8M<;2_P!G3]H2XT?3=>UF[E;^S?AK\2-/=[/PIX^NMPD2S\/7
M]M>7'AGQO<1"W$5A-H7B+4;EK'P?]FF^)_\ @I[_ ,$_/'7_  3O_:9\1?"S
M6(-0U3X7>)IM0\4_ WQ]/"YM/%_@&:['E6%S>*B0'Q?X->YM_#_C*P"PRQWZ
M6FM06J:'XAT*YO/SGK^O,9A<GXUX<G0E-8K*LYPD)TJU)I3C=QJ4:U-M/V>(
MPU:$9<DXMTZU-TZL':<'[<HPKTK7O"<4TU]Z:[-/[FK,_P!C.&:&YABN+>:*
MXM[B*.:">&1)89H94$D4T4L99)(I$97CD1F1T8,I((-2U_GE_P#!,C_@OE\<
M?V)M)T+X-?&W2=6_:#_9RTE+;3M L)M72#XH?"W28GCC2S\#Z_JIDM/$'AK3
M[0/'IW@+Q+<6EG9)%96'A[Q-X5TFV>RG_KS^ 7_!9?\ X)M?M#Z7IUUX;_:B
M^'W@+6[U(%G\'?&S4X/@]XDT^_G**FDL_CB72_#FM:@7ECB3_A$_$'B*RN)7
M\FTO+B59$3^1^)O#?B?AO$5(RP%?,L I/V.99?0J8BC.G]EUZ=-5*N#J6LIP
MKI0Y[JE5K12F_%K86M2;]USCTG%-JWFE=Q[:]=F]S]0:*^<-;_;'_9%\-Z5!
MKGB']J?]G+0]%NK:2]M=5U;XW?#33].N[2%8FEN;6\N_$T5O<PH+B M)!)(H
M\^$9S+&&_*']K+_@XG_8%_9^TG4K#X3>(]1_:F^(\*W$-CX<^&45WIG@B&]C
M)$3Z]\4M=TU-!&ES%7"7G@JR\>760F_3XX95N!\[EO#/$&;UXX?+LFS'%5)2
MY;PPM6-*#O:]:O4C"A0BFK.=:I"*>C=S*-&K-\L:<F_1I+U;LDO-M(_57]KO
M]K'X0_L5_ GQG\?/C/KD.F>&_#%G)'H^BQ7%NGB#QUXLGM[B30? WA&SGD0Z
MCXBU^XMWC@C4?9]/LH;_ %S5I;/1-*U._M?\MC]I_P#:'\>?M8?'_P"*O[1'
MQ*G1_%WQ3\67WB.\LX)9IK'0M.VQ6/A[PMI3W!,YT;PGX=L]*\-Z/Y[-/_9N
MEVIN'DG,DC>V_MV_\%#/VCO^"A7Q+@\??'3Q#;1:+H'VVV^'WPR\,1W.G^ /
MAYIE\T)NX="TRXN;NYO-6U+[-;/K?B76;N_US5GM[:WDNX=*L-*TO3_AFOZM
M\-O#^/!V$K8K'3IU\\S"G"&)G2;E2P>'4E-8.C-I.HW-1J8FJDHU*D*<8)PH
MQJ5/9PF&]A%RE9U)+6VT5ORKOKJWU>BT5V5_?'_P:R?\H^_C#_V>/\0?_5)_
ML]5_ Y7]\?\ P:R?\H^_C#_V>/\ $'_U2?[/5<_C/_R0^(_[&.7_ /IV0L?_
M +O+_%#\S[T_X+8?LJWG[6W_  3P^-'A+P_IS:GX]^&45E\=/AW:1P?:;FY\
M1?#6#4+K6=.L+=2LLVJ:_P##_4?&OAK28H665]2UFT4+,I>WF_S**_V.*_SG
M/^"Z7_!,W5/V(?VB]1^*WPY\//%^S%\?-?U77_!4^FVBII/PX\;WSS:KXE^%
M5VMK!%:Z39V\KW6L?#ZW9(8;KPD7TFR>]N_"6M3I\+X'\4T:,L9PKC*L82Q%
M66/RIS=E4JNG&.,PD6_MN%*GB*,%I+EQ+^)I2YLOK)<U&3LVW*%^KLE*/W*Z
M7^(^._\ @EY^W;K?_!/;]K/P=\;%M]0UCX>:K;3^!/C)X6T]Q]JU_P"&VOW5
ME+J4^G022PV\VO\ AG4;'3/%7A^*>:WCO-1T=-(GO+2QU2]F'^G?\-/B7X"^
M,?@+PI\4?A=XKT;QQ\/O'&C6NO\ A3Q7H%TMYI6L:5>*?+G@DPDL,T,JRVE]
M8W<5O?Z9J%O=:=J-K:W]K<VT7^/_ %^LG_!-;_@KY^T9_P $X]9?0/#R6_Q2
M^ &N:N=5\6_!+Q/J-Q8V27MPL4=[K_@#Q%'!?W'@?Q/=100QW=PFG:QH&JI&
MIUGP]?7D-C?V'V7B=X<3XKC3S?)_9PSS"T51G0J2C3I9EAH.4H4W4E:%+%4G
M*2HU*CC3J0E[*M.$84YT^C%X7VUIPLJB5FGHIKHF^C71O3HW:UO]-2BOQD_9
MJ_X+V?\ !-W]HC3=/35/C-#\ /&-Q#$;_P '_'NU'@>"QG*()S#X^\V^^&MY
M9"<R):RR>+++49K=4N;O2-/+F&/[Z;]M_P#8M2Q;5'_:]_9>335M#?MJ+?'[
MX4+8K8K#]H:]:[/BP6XM!;@SFY,@A$(\TOL^:OY?QG#N?Y?7EA\;DV9X:M%V
MY*F"Q"4M;7IS5-PJP;^&=.4X2WC)H\B5*I%VE3FGYQ?X.UGZH^H:\X^+WQ=^
M''P&^&OC'XO_ !<\6Z3X'^'?@/1KC7?$_B769Q!:6-E!M2*&% &GO]3U&[DM
M]-T?2+&*XU/6=6N[+2M,M;K4+RVMY?R:_::_X+]?\$X_V>-+OX_#OQ8;]HCQ
MM#%*-/\ !_P+M&\46-S<&.3[-)>_$.Z.G_#RTTYKA4CNYM/\1:SJ]O"YN;?0
MKX!8Y/XN?^"C_P#P5C_:/_X*.^)+:U\<36WP\^"GAW4VU'P3\$/"=]>3^'K"
M]C6Z@M?$7BW5+@07/C7QE'97<UFNLW=II^F:=!+<Q^'M T1;_4OMWVG"/A;Q
M#Q%BJ-3'83$Y/E"E&6(Q>,HRH5ZM)--T\%AJT8U:M2I&ZA6E!8:&LY3FTJ4]
MZ.#JU6G*+A#K*2LVO[J>K?G:R[]'_1Y^S9_P=$_!WQA\6_%_A+]I7X2ZG\*O
MA;J?C+5X_A9\5?"/V[Q+-HO@R34/)\.0?%[P8DNH:G'JT>F(;S7?$G@.\UNV
M-_<)IUGX+@M+6369_P"GGX9_%+X;_&?P7HOQ&^$OCKPK\1_ GB*W%SHOBSP;
MK>G^(-#OT&!+%'?Z=//#'=VLA,%]8S&*]T^Z22TO;>WN8I(D_P @2OZC?^#9
MK]G;]IKQ3\>O$OQ^\._$#Q]\./V7? :7FD>.]&TO5)[?PG\<?']SH\UOHG@N
M\T"\6XT76$\(VNJ+XEUGQ +"35?#ROI6EZ5?Z==>(WN[7]#\0O"WAK+,GQ>>
MY9BWDCP-"+EA*\JF)PF-J)*G2HT7.4L11Q>(G:*<95:,IN[HT8<]6/5B<'2A
M"52$O9\JV=W&3V2752;]5?HEJO[JZ***_F\\H*_RZ?\ @K7^R>W[&_[>OQV^
M%.G:<NG>!-:\0M\4?A4D,1BL1\.OB-)/X@T?3-.5E1FM/".HRZQX#:1D&^[\
M*W3(\L92:3_46K^53_@Z,_9//C7X%?"3]K_PWI2RZW\%?$(^&OQ'O;>%?/;X
M;_$*]C/A;4M1N",FQ\,_$,0:-80JV1>_$JXD",I=H_U?P=S_ /L?BRG@:L^7
M"9[2_L^:D[16+BW5P$_.<JJGA8+OBWI>UNS U?9UE%NT:BY/+FO>/XWBO\1_
M#K'))#)'+%(\4L3K)%+&S))'(C!DDC=2&1T8!E92&5@""" :_P!+#]FK_@II
MX2US_@D3I?[?'Q"U*'4]:^%_P<U*R^)]C/<+;W6M_&SP'L\$CP^[F29;+4/B
MEXV_X1^XT%)IB$M_'.BR7$D0>39_FF5]$Z/^U#\6=#_9<\9_L@Z?K?D?!SQS
M\8/"_P :]:TF,21W$OBSPUX:U'PTT#2HX2;2=7AD\-ZCJ-G/&X.J>"O#5W"T
M;6KB3^AN.N#*/&-#)Z4Y1ISR_-</7JS;:G/+:LHPS+#TY)>[.K3C3G!Z+VE&
M'<]3$8=5U33TY9IONX/XTGW:2:\T>4_$;X@>*OBO\0?''Q0\=:I+K7C3XB^+
M?$7C?Q9J\V1)J7B/Q3JUWK>LWI4LWEBXU"]N)$B4E(D98DPB*!Z1^RY\ /%G
M[5'[0_P>_9Y\$K*/$'Q9\=:+X4CO8[:2\70])N)C<^)?%%W;Q?O)-.\)^&K7
M5_$VJ;<%--TFZD) 4D>"5_7M_P &N'[&_P#:GB7XN_MP^+])W6?AB&X^"GP<
MEO+?*-X@U6VL-7^)GBC3S/ KI/I>A3:#X1T_4K*=X9X?$WC32YU$UJX3TN+L
M\H\*<,YAF<%"G/"X98?+Z*45%XNJE0P=.,+6<*<W&I."5E0I5'9*+M5>HJ-*
M<_Y5:*_O/2.G9-IOR3/["/AA\.?"?P?^&_@+X4>!-.&D^"_AMX/\.>!?"FG#
MRRUGX?\ "VD6FBZ5#*\4<*37 L[*$W-P(D-Q<&6=U#R-7=445_"=2<ZLYU:D
MI3J5)RG4G)N4ISFW*4I2>KE*3;;>K;;9\[ON%?R\?\'5'_)GG[.__9RL/_JK
MO']?U#U_+Q_P=4?\F>?L[_\ 9RL/_JKO']?;>&G_ "77#G_8;/\ ]1<0=&$_
MWBE_B_1G\)U?VF_\&G?_ "3_ /;7_P"QQ^!__ID^)E?Q95_:;_P:=_\ )/\
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MNE:/UF@OJ>(BO[W+0HUI]Y5[O5L\3'PY:_-TJ14OFO=?Y)OU"OQV_P""LO\
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M2+E&7PMV?+):Z.ST:C?I:[/V(HHHK^>SS HHHH **** "BBB@ HHHH ****
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M>HE*&&HWYJM2[?+2A5J4]J%&5>:BKJ*UG+I&/^;Z+J_)-K\D/^"HG[<NL?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /Q8_X+\_LW:Q^T=_P3C^(</A
M+P_J?BCQY\(?&7@7XN^#M"T/2[K5M:U6XTS5)/!WB2STZSL(I[ZXF3P3XU\3
M:BMK:P7#W4VG00B'>R2Q?Q(?!?\ X)"_\%)/CO?VEIX._9%^+F@V5V8F_P"$
M@^*>@-\'O#T5I* YU!-3^)TGA5=1M$BS*!HL>IW5PH\NSMKF=XXG**_:N"N-
M,WX:X)S&6!IX*O\ 5\TKRHK&TJ]2-/VN&P;E%*CB,/[O.Y5$FV^><FVTTEWX
M>O.CAY.*B[3=N9-[QCV:/Z)/V,?^#73PUHEYI7C+]N;XKQ>-&A%M=M\%_@Q=
M:II'AR67B1[+Q9\3=0M=-\2ZE:-&YMKS3O!^B^%;J&YB,UAXRNK8@2?U7_"O
MX2_#+X'>!="^&7P@\">&/AQX \-6YM]$\)^$=)M=&T>R61C)<3_9[6-/M%]>
MSE[K4=2NVGU#4KR26\O[JYNII9G**_.>(>+N(.**JJ9SF%7$4X2<J.%@HT<'
M0;35Z6&I*--347R^UFIUI1TG4D<M6O5K.]23:6T5I%>B6E_-W?F>AT445\V9
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>aldx-20250819.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-08-18T19:40:25.1764+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.aldeyra.com/20250819" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:aldx="http://www.aldeyra.com/20250819" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>75000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="aldx-20250819.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001341235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 19,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALDEYRA THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1968197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">131 Hartwell Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lexington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">761-4904<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ALDX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="aldx-20250819.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>75000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="aldx-20250819.htm">aldx-20250819.htm</File>
    <File>aldx-20250819.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "aldx-20250819.htm": {
   "nsprefix": "aldx",
   "nsuri": "http://www.aldeyra.com/20250819",
   "dts": {
    "inline": {
     "local": [
      "aldx-20250819.htm"
     ]
    },
    "schema": {
     "local": [
      "aldx-20250819.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "longName": "75000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_f19ad44d-647b-481c-bf31-53994eb97360",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aldx-20250819.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f19ad44d-647b-481c-bf31-53994eb97360",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aldx-20250819.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.aldeyra.com/20250819/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0000950170-25-109932-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-109932-xbrl.zip
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M=9I^"[YN[/Z$=@:<,OB+=HJX2/BNA__8:94_Y<LA+Z@B7LS_&L?GGS:Z65H
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M-HA/U(-LN0"N7:C3"6!6"@[6* AZ,$/C,_DRRZDF9XX6QBJ=ME&<R.E);^D
MI%6!?%\C<O#**=H="R';+--U(NC\,I6;G(#*XU9=80C-@#TN>,2%/"F! ,X\
M3AMW:J->U4"],@SM?BWI9C77U>Y7RAKEJB9Z@%*N_$:Y6O&=F)6?4]UU(Z5)
M></%3& T&E>=F/]K37J3?;Q$B$;XU4SX>9KS&.'WF$-AOJZ9M9.8"F>D"RPM
ME)OU9:/KYR7"_$@P5-=A719&0S0+P%<S9O$XP3%C!SN!:.T>9:L7R<TID_4Z
M97(;'1!7<UWSC2 ]V.FAB$?%M8O2U_ZXQ;H3A_1J-$9!?5A+W4!'T4#(F"N:
ML GF$]__DVB#8G@[4*-H.5!5VXR'6>G/:ZL4('(K=9X_<OXCIP%N=UPN>O.8
M\L%=<WQ>KARM-R<:QHPEO%8XL4;DU$"O@=Y3H%<S9E WZ?!LJT'F[AE\JZ)U
MC1C!NP%=-X.9HV-ZQD&1*$"O"-4%QGNTH.@@3CC:Y,. ,QF_*N-?XU3M,?94
M3!CZ]NO)(6)9.):^X+KF+7M3L:+O::YK'!?;W.?W=F?;Q#PW,<]-S',=B*_V
M,<\UO["YW_OMJ'/Z]63_/>Y3O\O-^>.Y(VCE";F_QB"KRE".AYV;WEIVM(Z-
MDRD*Z5@>AU/A@J(,$X1N HYDP")\R%(40S<!'] DDA&"LB'E%9T5D'&"XQ3J
MJ.: \0XR 0!@:Q0Y:-0MI:U-GC.>P'_(D8.EL0$/..+P7*XHF):$[*<-8V.I
MU&[< PL)B/;_<])!I[_OGW2.][^>]KK]+=0[ZMX3ZU6_)6M<NS5S[=X24Z#I
M!GF3B_+KM+U&<1GK".%6WD*G&6.HJZ%?!673-2:#-TD"+QF8]/:@)Y.7M1<1
M''W6]K0M=#R /PVRUVNY&F1_"O143MLVZ@YB'H$="C:IVI?Z$D5QR$5-MYH:
M7\8+3GKOSB"GQE'?..JO.^IW6D'&IKL_[;0&Q3#9_7]02P,$%     @ ##@3
M6PJ(,*-\"0  CG@  !$   !A;&1X+3(P,C4P.#$Y+GAS9.U=;7.;.!#^?K]"
MYWYIYXJQG:1)/'$ZN:2Y\5R:9&)WKG,W-QT,LL,42SX!L?WO3P+D(! 8VXG
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M9%+H;SM>6M^%]?4T-+A4A25E6&<5*_!*I^5\-(61$MR'-T.T5]=S/=&E".Y
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MW9K!0#9C$U-12"$4 ;TN!0_JZI9FF>5S*)UAR(V43!OSWB W/53P.30OB2X
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M=#MG3H%PH+$].?8\.#:1-TSP!!Q^2U=UP. BG/. B<1P\*HV<<NTKZZ3N;3
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M.#$Y+GAS9%!+ 0(4 Q0    (  PX$UN3C+)+^A,  &YI   /
M  "  7L=  !A;&1X+65X.3E?,2YH=&U02P4&      ,  P"[    HC$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>aldx-20250819_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aldx-20250819.xsd" xlink:type="simple"/>
    <context id="C_f19ad44d-647b-481c-bf31-53994eb97360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001341235</identifier>
        </entity>
        <period>
            <startDate>2025-08-19</startDate>
            <endDate>2025-08-19</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_7b26f16c-c78a-49bf-ad16-71b6da387efe">0001341235</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_b96d9d44-debf-4e74-82f4-f82da2e3e21d">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_1a90d194-0a26-4320-943e-0f99a2f2c2bc">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_aeb6ef36-d8bb-4b5b-b397-260df7c50884">2025-08-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_9c5163ab-b8f6-474e-ad03-c3c08ed8e85d">ALDEYRA THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_ea73ae7c-3933-46d3-a339-6125883d51ea">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_603139cf-c295-4d97-a4a6-4bda021ff651">001-36332</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_cb31cb55-a644-4cc2-8f88-72af22260501">20-1968197</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_8ce705e4-eeb1-4e15-80a8-03eb4576f835">131 Hartwell Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_160770b5-7163-4be2-afa4-0345501088fd">Suite 320</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_2ea42e45-a36e-4f56-bdff-72662ab5cab8">Lexington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_dc8b6cec-b74f-4f25-881d-1466fa06eea6">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_313525a3-2483-429a-ba9b-5d9c40011a87">02421</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_277af634-def2-4e54-a593-557be14536af">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_b28fdbd4-790c-4e00-a9d4-650d54b1aaa1">761-4904</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_e7ddc68b-21ce-4980-9e7e-7beac90ae78e">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_ffb9ba79-ff91-4239-a346-ee6dc113e9d5">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_9fadafb4-5607-44d2-a902-7107f3e3cf46">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_9e2acebd-29a6-408d-aa6f-011e8dc384d9">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_6587283a-70bb-4364-9933-887578a759bb">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_fcdb31dd-8fe1-4074-b323-edbea9e00de7">ALDX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_5b6bb2b8-d26b-4825-a4a4-8989f3e57a9f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_f19ad44d-647b-481c-bf31-53994eb97360"
      id="F_75872da6-bd71-41d5-a669-ce729640d387">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
